The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
about
Treatment of hepatitis C in children: a systematic reviewMorphologic features of extrahepatic manifestations of hepatitis C virus infectionEpidemiology of hepatitis C virus infectionAlcoholic liver disease and hepatitis C: a frequently underestimated combinationBlood-borne pathogens among firefighters and emergency medical techniciansExposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strainAlpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replicationHepatitis C-Z: recent advancesSafety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety TrialClinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States.Stainable hepatic iron in 341 African American adults at coroner/medical examiner autopsyPhysicians' preference values for hepatitis C health states and antiviral therapy: a surveyRisk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillanceThe spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-alpha2beta and Ribavirin.Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infectionA scoping review of home-produced heroin and amphetamine-type stimulant substitutes: implications for prevention, treatment, and policyHepatitis C cirrhosis: New perspectives for diagnosis and treatmentCurrent status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6Update on the treatment of patients with non-genotype 1 hepatitis C virus infectionDaclatasvir: potential role in hepatitis CViral infections during pregnancyVirus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3Generation and characterization of a hepatitis C virus NS3 protease-dependent bovine viral diarrhea virusDetection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCVEffect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical studyEpidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins.Comparative Analysis of Anti-Hepatitis C Virus Activity and Gene Expression Mediated by Alpha, Beta, and Gamma InterferonsBroad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus InfectionA comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decadesAntiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.The natural history of hepatitis C virus (HCV) infection.Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in CulturePrimary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infectionEffect of hepatitis C virus core protein on the molecular profiling of human B lymphocytesComplement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoproteinAmphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA ReplicationMultitypic Hepatitis C Virus Infection Identified by Real-Time Nucleotide Sequencing of Minority GenotypesDepression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction
P2860
Q21136318-F05240BF-5C2A-410F-886E-837E975EFCD1Q21284981-AEDBC77D-44F9-449A-8A20-EE5C95BFE5DBQ22305500-4612A218-9CC5-4E74-8D32-0E311F293F15Q22305502-5240FBCD-A25B-4880-A322-EF79A4FF717AQ23923835-C6B04223-2E8A-412B-A2C7-A39B8D21C004Q24529494-638C71AD-8F01-4FFC-8A0A-23E89025EFEAQ24551046-D86E0353-99B4-4ADE-BE29-E8EA70CDC96DQ24676346-6C4911BD-BE90-4F73-9E6A-9B113F1A9A3DQ24683611-F0B4100C-3938-4D57-B634-F8A01A5BF08AQ24791398-59D01A77-F1C7-4DC1-A95E-22596D2D921DQ24795077-2E406809-0C45-41F2-9F23-5DD29BC81E41Q24802683-4DA8E970-62A1-4612-A10A-07BFA072C9D8Q24803011-CC6B6677-C18D-4A5A-A25B-850CEE26EF62Q24816546-F37636B0-EDE2-453F-B250-C8FF8F6BE4FCQ26740216-8E8B79A3-7C6E-4DC6-AA9D-841A912CD5DEQ26752324-DA2522A8-1C10-49D7-8A58-4ECF0DFD353AQ26799924-B8615FC4-8E38-4403-8CFB-3FCA978E1705Q26828972-49A19D29-F4D8-4724-904F-06797F9379FCQ27000806-A0C17FB6-814F-4CF7-BD3D-E8B07CBF1AEBQ27012741-484C082F-A7D1-4F17-BE94-F4715632D64CQ27027087-1B434F4F-89AA-4557-90E0-A9AF2FFCC7CCQ27469660-DBB31706-61AE-4C24-8DD6-B35C6049297BQ27469675-5C600B9F-A52C-46AF-8C0D-E8E0E60ABD9AQ27469764-9671E47F-1B22-4904-95F7-C7D743F62166Q27472607-E27E5E98-68C9-4A03-9EE1-35E470E64DC1Q27472758-C37D5AF2-8CD1-4088-818D-E62ED116F97AQ27472837-867D8FB4-0AD9-42DD-8CF2-42C0F1023FD7Q27472885-D1B98D99-A143-4780-A65F-83B56283C7BDQ27472908-3365D253-6B57-4213-861D-15DA188722DCQ27472915-31FC4785-796B-4428-840C-11C0F8AF38F5Q27473000-3AB5466E-0E57-49F5-BEFA-E60940D3005BQ27473083-0223218A-D564-4AF0-8E9A-41CCFF1741D6Q27473116-34B64E76-D655-4E9B-A30E-EC663FB0118BQ27473305-531D82AE-544D-4D35-881F-1A5FD9FBBBABQ27473382-5C073C90-4848-4628-81AD-0409C1E6BBC6Q27473390-ED7837B1-A825-4289-86C2-E449ED241194Q27473461-363175F8-43BD-42EE-A1F1-B15C3B0A1B2EQ27473477-8B68B77C-7852-4DDA-AF76-151854F22B86Q27477500-7EDBE39F-3F23-4764-B4F8-83C53D1873EFQ27477533-6AF66326-BD0A-47FA-A024-D501E60D4ABD
P2860
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
@ast
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
@en
type
label
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
@ast
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
@en
prefLabel
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
@ast
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
@en
P2093
P3181
P1476
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
@en
P2093
Kruszon-Moran D
Margolis HS
McQuillan GM
P304
P3181
P356
10.1056/NEJM199908193410802
P407
P577
1999-08-19T00:00:00Z